You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

P50 suppression

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Schizophrenia Trial in Glendale, Rouffach, Toul (NSA-789 at 2 different doses)

Withdrawn
  • Schizophrenia
  • NSA-789 at 2 different doses
  • Glendale, California
  • +2 more
Aug 17, 2021

Burst Suppression During General Anesthesia, Anesthetic-induced Burst Suppression, Identification of Burst Suppression in the

Active, not recruiting
  • Burst Suppression During General Anesthesia
  • +3 more
  • MATLAB-based interface, showing 50 EEG traces, classification of the EEG-pattern as Burst Suppression possible, yes, no.
  • Munich, Bavaria, Germany
    Klinikum rechts der Isar - Klinik für Anästhesiologie und Intens
Aug 17, 2022

EX-PRESS® P-50 and EX-PRESS® P-200

Not yet recruiting
  • Glaucoma
  • EX-PRESS P-50 filtration device
  • EX-PRESS P-200 filtration device
  • (no location specified)
Oct 31, 2023

HIV Trial (DTG/3TC)

Not yet recruiting
  • HIV
  • (no location specified)
Jun 9, 2023

AIDS Trial (Dolutegravir 50 MG plus lamivudine 300 MG; Dolutegravir/lamivudine (50 MG/300 MG))

Not yet recruiting
  • Acquired Immunodeficiency Syndrome
  • Dolutegravir 50 MG plus lamivudine 300 MG； Dolutegravir/lamivudine (50 MG/300 MG)
  • (no location specified)
Aug 6, 2022

Bioequivalence, Diabetes, Type 2 Trial in Mount Royal (Sitagliptin/Metformin HCl 50/850 mg film-coated tablet)

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/850 mg film-coated tablet
  • Mount Royal, Quebec, Canada
    Algorithme Pharma
Sep 20, 2022

Bioequivalence, Type 2 Diabetes Trial in Mount Royal (Sitagliptin/metformin HCl (HCl) 50/1000 mg film-coated tablet)

Completed
  • Bioequivalence
  • Type 2 Diabetes
  • Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet
  • Mount Royal, Quebec, Canada
    Algorithme Pharma
Sep 20, 2022

HIV-1-infection Trial in San Francisco (Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch)

Completed
  • HIV-1-infection
  • Bictegravir/emtricitabine/tenofovir alafenamide + Doravirine switch
  • San Francisco, California
    SFOMG Private Practice
Jan 27, 2022

Breast Cancer Trial in New York (Multicomponent Adherence Intervention)

Recruiting
  • Breast Cancer
  • Multicomponent Adherence Intervention
  • New York, New York
    Columbia University Medical Center
Nov 6, 2023

SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)

Recruiting
  • SARS-CoV-2 Infection
  • B/HPIV3/S-6P
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health
Aug 30, 2023

Bioequivalence Trial in Mount Royal (Lamotrigine ER tablet 50mg)

Completed
  • Bioequivalence
  • Lamotrigine ER tablet 50mg
  • Mount Royal, Quebec, Canada
    Algorithme Pharma
Dec 6, 2021

Healthy Trial in Québec (Camlipixant + Gemfibrozil, Dabigatran etexilate + camlipixant)

Not yet recruiting
  • Healthy
  • Camlipixant + Gemfibrozil
  • Dabigatran etexilate + camlipixant
  • Québec, Quebec, Canada
    Syneos Health
Jul 17, 2023

Healthy Trial in Québec (Camlipixant + Rifampin, Camlipixant + Rabeprazole)

Not yet recruiting
  • Healthy
  • Camlipixant + Rifampin
  • Camlipixant + Rabeprazole
  • Québec, Quebec, Canada
    Syneos Health
Jun 2, 2023

Nasonex® Nasal Suspension 50 µg Long-term Designated Drug Use

Completed
  • Allergic Rhinitis
  • mometasone furoate
  • (no location specified)
Feb 7, 2022

Healthy Trial in Mexico City (Fixed dose combination Pregabalin 150 mg / Tramadol 50 mg, Pregabalin 150mg, Tramadol 50 mg)

Completed
  • Healthy
  • Fixed dose combination Pregabalin 150 mg / Tramadol 50 mg
  • +2 more
  • Mexico City, Mexico
    Laboratorio Silanes, S.A. de C.V.
May 19, 2022

Migraine Headache Trial (rizatriptan benzoate (MK0462), Comparator: sumatriptan, Comparator: Placebo)

Completed
Has Results
  • Migraine Headache
  • rizatriptan benzoate (MK0462)
  • +2 more
  • (no location specified)
Feb 1, 2022

Cervix Cancer, HPV Testing, Postmenopausal Women Trial in Randers (cytology, p16/ki67 dual stain cytology (DS), extended

Recruiting
  • Cervix Cancer
  • +2 more
  • cytology, p16/ki67 dual stain cytology (DS), extended genotyping, DNA methylation, viral load,
  • Randers, Central Denmark Region, Denmark
    Department of Pathology
Feb 3, 2023

Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Seoul (PPI, P-CAB 25, P-CAB 50)

Recruiting
  • Coronary Artery Disease
  • +3 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Mar 6, 2022

Group A Streptococcal Infection Trial in Edmonton (p*17-K4S2 (25 µg/mL), J8-K4S2 (100 µg/mL), p*17-K4S2 (50 µg/mL))

Not yet recruiting
  • Group A Streptococcal Infection
  • p*17-K4S2 (25 µg/mL)
  • +4 more
  • Edmonton, Alberta, Canada
    University of Alberta Hospital
Jul 26, 2022

Based Care for Youth in Low-resource Environments

Recruiting
  • Improving Therapist Use of Measurement-based Care
    • Seattle, Washington
      KPWHRI
    Nov 30, 2022

    Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK744, GSK744 LA, TMC278 LA)

    Active, not recruiting
    Has Results
    • Infection, Human Immunodeficiency Virus
    • HIV Infections
    • Birmingham, Alabama
    • +49 more
    Dec 26, 2022

    Sickle Cell Disease Trial in Paris (Famotidine 400 mg/50 mL)

    Recruiting
    • Sickle Cell Disease
    • Famotidine 400 mg/50 mL
    • Paris, France
      Necker - Enfants malades Hospital; Department of Pediatrics and
    Oct 10, 2022

    Covid19 Trial in Ottawa (drug, dietary supplement, other)

    Suspended
    • Covid19
    • Vitamin D3 50,000 IU
    • +4 more
    • Ottawa, Ontario, Canada
      The Centre for Health Innovation
    Aug 8, 2022

    Drug Interaction Trial in Montréal (ATI-2173 50 mg, Tenofovir 300Mg Oral Tablet)

    Completed
    • Drug Interaction
    • ATI-2173 50 mg
    • Tenofovir 300Mg Oral Tablet
    • Montréal, Quebec, Canada
      Altasciences
    Feb 3, 2022

    Healthy Adults Trial in Dallas (Sitravatinib 50 mg, Sitravatinib 100 mg, Itraconazole)

    Recruiting
    • Healthy Adults
    • Sitravatinib 50 mg
    • +3 more
    • Dallas, Texas
      Labcorp Drug Development Clinical Research Unit
    Feb 23, 2022